MedPath

Methamphetamine Hydrochloride

Methamphetamine Hydrochloride Tablets, USP

Approved
Approval ID

f31f580f-1f08-4a0f-b078-0b9e3308f712

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 5, 2023

Manufacturers
FDA

Mayne Pharma Commercial LLC

DUNS: 867220261

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

METHAMPHETAMINE HYDROCHLORIDE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68308-115
Application NumberANDA091189
Product Classification
M
Marketing Category
C73584
G
Generic Name
METHAMPHETAMINE HYDROCHLORIDE
Product Specifications
Route of AdministrationORAL
Effective DateJuly 5, 2023
FDA Product Classification

INGREDIENTS (5)

STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
METHAMPHETAMINE HYDROCHLORIDEActive
Quantity: 5 mg in 1 1
Code: 997F43Z9CV
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Methamphetamine Hydrochloride - FDA Drug Approval Details